SpringWorks Therapeutics: Q4 Earnings Snapshot

February 24, 2022 GMT

STAMFORD, Conn. (AP) _ SpringWorks Therapeutics Inc. (SWTX) on Thursday reported a loss of $56.1 million in its fourth quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of $1.15.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 87 cents per share.

For the year, the company reported a loss of $173.9 million, or $3.59 per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SWTX at